NL190701C - Werkwijze voor de bereiding van 6,7-dimethoxy-4-amino-2-[4-(2-furoyl)-1-piperazinyl]chinazolinehydrochloride. - Google Patents

Werkwijze voor de bereiding van 6,7-dimethoxy-4-amino-2-[4-(2-furoyl)-1-piperazinyl]chinazolinehydrochloride.

Info

Publication number
NL190701C
NL190701C NL8000289A NL8000289A NL190701C NL 190701 C NL190701 C NL 190701C NL 8000289 A NL8000289 A NL 8000289A NL 8000289 A NL8000289 A NL 8000289A NL 190701 C NL190701 C NL 190701C
Authority
NL
Netherlands
Prior art keywords
furoyl
piperazinyl
dimethoxy
amino
preparation
Prior art date
Application number
NL8000289A
Other languages
English (en)
Dutch (nl)
Other versions
NL190701B (nl
NL8000289A (nl
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of NL8000289A publication Critical patent/NL8000289A/nl
Publication of NL190701B publication Critical patent/NL190701B/xx
Application granted granted Critical
Publication of NL190701C publication Critical patent/NL190701C/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NL8000289A 1979-01-31 1980-01-16 Werkwijze voor de bereiding van 6,7-dimethoxy-4-amino-2-[4-(2-furoyl)-1-piperazinyl]chinazolinehydrochloride. NL190701C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI790320 1979-01-31
FI790320A FI67699C (fi) 1979-01-31 1979-01-31 Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan

Publications (3)

Publication Number Publication Date
NL8000289A NL8000289A (nl) 1980-08-04
NL190701B NL190701B (nl) 1994-02-01
NL190701C true NL190701C (nl) 1994-07-01

Family

ID=8512343

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8000289A NL190701C (nl) 1979-01-31 1980-01-16 Werkwijze voor de bereiding van 6,7-dimethoxy-4-amino-2-[4-(2-furoyl)-1-piperazinyl]chinazolinehydrochloride.

Country Status (21)

Country Link
US (1) US4271300A (no)
JP (1) JPS55104280A (no)
AT (1) AT374475B (no)
BE (1) BE881297A (no)
CA (1) CA1128945A (no)
CH (1) CH644605A5 (no)
CS (1) CS214692B2 (no)
DD (1) DD148952A1 (no)
DE (1) DE3002553A1 (no)
DK (1) DK158352C (no)
FI (1) FI67699C (no)
FR (1) FR2447920A1 (no)
GB (1) GB2041932B (no)
HU (1) HU181016B (no)
NL (1) NL190701C (no)
NO (1) NO152298C (no)
PL (1) PL126994B1 (no)
SE (1) SE430692B (no)
SU (1) SU900812A3 (no)
YU (1) YU41498B (no)
ZA (1) ZA80501B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI70411C (fi) * 1980-12-29 1986-09-19 Pfizer Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
FI79107C (fi) * 1984-06-25 1989-11-10 Orion Yhtymae Oy Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation
AT384218B (de) * 1985-12-04 1987-10-12 Gerot Pharmazeutika Verfahren zur herstellung von neuen chinazolin-derivaten
YU70890A (en) * 1989-04-21 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for obtaining quinazoline derivatives
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
GB1390015A (en) * 1971-05-07 1975-04-09 Koninklijke Pharma Fab Nv 4-amino-quinazoline compounds
US3935213A (en) * 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
FI58124C (fi) * 1976-12-15 1980-12-10 Orion Yhtymae Oy Ny mellanprodukt 3,4-dimetoxi-6-(4-(2-furoyl)-1-piperazinyltiokarbamido)-bensonitril foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande verkan
FI58125C (fi) * 1976-12-15 1985-01-02 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande vekan

Also Published As

Publication number Publication date
CS214692B2 (en) 1982-05-28
NO152298B (no) 1985-05-28
CH644605A5 (de) 1984-08-15
PL221684A1 (no) 1980-10-20
ATA19580A (de) 1983-09-15
DK158352C (da) 1990-10-08
SE430692B (sv) 1983-12-05
SE8000777L (sv) 1980-08-01
DE3002553C2 (no) 1988-10-27
BE881297A (fr) 1980-05-16
AT374475B (de) 1984-04-25
NO152298C (no) 1985-09-04
PL126994B1 (en) 1983-09-30
FR2447920A1 (fr) 1980-08-29
FI67699B (fi) 1985-01-31
NL190701B (nl) 1994-02-01
ZA80501B (en) 1981-02-25
FR2447920B1 (no) 1982-12-03
JPS55104280A (en) 1980-08-09
DK158352B (da) 1990-05-07
FI67699C (fi) 1985-05-10
YU41498B (en) 1987-08-31
GB2041932A (en) 1980-09-17
GB2041932B (en) 1982-10-27
US4271300A (en) 1981-06-02
NO794279L (no) 1980-08-01
DE3002553A1 (de) 1980-08-07
DD148952A1 (de) 1981-06-17
JPS6310955B2 (no) 1988-03-10
YU5880A (en) 1983-02-28
DK42680A (da) 1980-08-01
HU181016B (en) 1983-05-30
SU900812A3 (ru) 1982-01-23
FI790320A (fi) 1980-08-01
CA1128945A (en) 1982-08-03
NL8000289A (nl) 1980-08-04

Similar Documents

Publication Publication Date Title
NL191149C (nl) Werkwijze voor de bereiding van 3-trifluormethylpyridinederivaten.
NL189127C (nl) Werkwijze voor de bereiding van 1,1-diesters.
NL7807432A (nl) Werkwijze voor het bereiden van 1,2,4-triazine-5-on-de- rivaten.
NL191313C (nl) Werkwijze voor de bereiding van p-chlooralkylbenzeen.
NL7802824A (nl) 11,12-seco-prostaglandinen alsmede werkwijze voor het bereiden daarvan.
NL7706056A (nl) Werkwijze voor de bereiding van 5,6-cis- en 5,6-trans-10,19-dihydrovitamine d derivaten.
NL187577C (nl) 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
NL181923C (nl) Werkwijze voor de bereiding van beta-aminopropionamide.
NL190701C (nl) Werkwijze voor de bereiding van 6,7-dimethoxy-4-amino-2-[4-(2-furoyl)-1-piperazinyl]chinazolinehydrochloride.
NL7808881A (nl) Werkwijze voor de bereiding van 1,1,1,2-tetrafluore- thaan.
NL8004231A (nl) Werkwijze voor het bereiden van 7-alkoxycarbonyl-6, 8-dimethyl-4-hydroxymethyl-1-fthalazon en tussenprodukten daarvan.
NL7707639A (nl) Werkwijze voor de bereiding van oxocyclopen- tyl- en oxocyclohexylverbindingen.
NL7702823A (nl) Werkwijze voor de bereiding van 2-(2,2-dicy- clohexylethyl)piperidine.
NL189132C (nl) Werkwijze voor het bereiden van 2-(4-(2-furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxychinazoline.
NL7614574A (nl) Werkwijze voor de bereiding van 3,4-dihydro- -2(1h)-chinazolinederivaten.
NL7804406A (nl) Werkwijze voor de bereiding van 1.2-dichloorethaan.
NL7810456A (nl) Werkwijze voor het bereiden van 6,11-dihydro-11-oxodi- benz (b,e)-oxepine-2-azijnzuur en tussenprodukten daarvoor.
NL7808571A (nl) 2,3-polymethyleen-4-oxo-4h-pyrido/1,2-a/pyrimidinen en werkwijze voor de bereiding daarvan.
NL7901164A (nl) Werkwijze voor het bereiden van beta-santalol, beta-santaleen, dihydro-beta-santalol en verwante verbindingen.
NL7803465A (nl) Werkwijze voor het bereiden van 2-(2',2',2'- -trihalogeenethyl)-4-halogeencyclobutan-1-onen alsmede van cyclopropaancarbonzuurderivaten.
NL7706640A (nl) Werkwijze voor de bereiding van 2,9-dioxatri- cyclo(4,3,1,03-,7)decanen.
NL7806321A (nl) Piperazinecarbodithiozuurderivaten, werkwijze voor de bereiding daarvan en geneesmiddelen daaruit.
NL8001205A (nl) Spectinomycine-analoga, werkwijze voor het bereiden daarvan en daaruit bereide farmaceutische preparaten.
NL181433C (nl) Werkwijze voor het bereiden van cyclo-1,3,2-oxazafosforylderivaten.
NL7810359A (nl) Werkwijze voor het bereiden van n-(n'-ethylpyrrolidi- no-2-methyl) -alfa,alfa -difenyl- alfa - hydroxyaceet- amide.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee

Effective date: 19960801